Chemotherapy uses anticancer medicines to destroy cancer cells or limit their growth and multiplication. Dr. Nitin Yashas Murthy has expertise in administering systemic chemotherapy for different solid tumours and blood cancers. Treatment selection depends on cancer type, stage, medical condition and individual treatment goals, with regular monitoring for possible side effects.
Immunotherapy uses treatments that help the body's immune system recognise or attack cancer cells. Dr. Nitin Yashas Murthy has clinical and research experience with immune checkpoint inhibitors and immunotherapy-related adverse effects. Treatment may be considered for selected cancers based on clinical evidence, biomarkers and individual patient factors.
Targeted cancer therapy uses medicines designed to act on specific molecular pathways involved in cancer growth and survival. Dr. Nitin Yashas Murthy specialises in targeted treatments for selected malignancies, including cancers with identifiable molecular changes. Genetic or biomarker testing may help determine whether targeted medication is appropriate.
Molecular oncology studies the genetic and molecular characteristics of cancer to help guide treatment decisions. Dr. Nitin Yashas Murthy has additional training in cancer genomics and precision oncology. These approaches may involve evaluating tumour biomarkers and selecting systemic therapies based on the biological features of an individual cancer.
Breast cancer treatment may involve chemotherapy, hormonal medicines, targeted therapy, immunotherapy, surgery or radiation depending on the cancer subtype and stage. Dr. Nitin Yashas Murthy provides medical oncology management for breast cancer and has completed specialist breast cancer preceptorship programmes at international cancer institutions.
Lung cancer management depends on cancer type, stage, molecular characteristics and the patient's overall condition. Dr. Nitin Yashas Murthy has expertise in treating lung malignancies through systemic treatment options such as chemotherapy, targeted therapy and immunotherapy when clinically appropriate. Biomarker assessment can help guide personalised treatment planning.
Gynaecological cancers include malignancies affecting the ovaries, uterus and other female reproductive organs. Dr. Nitin Yashas Murthy has experience in systemic treatment of ovarian and uterine cancers. Medical oncology management may involve chemotherapy, targeted treatment or immunotherapy as part of multidisciplinary cancer care.
Gastrointestinal cancers affect organs within the digestive system, including the stomach and intestines. Dr. Nitin Yashas Murthy manages gastrointestinal malignancies using appropriate systemic therapies. Treatment planning depends on the location, stage and molecular characteristics of the cancer and may involve coordination with gastrointestinal surgeons and other specialists.
Colon cancer develops in the large intestine and may require surgery, chemotherapy, targeted therapy or immunotherapy depending on its stage and molecular features. Dr. Nitin Yashas Murthy has expertise in the medical management of colon cancer, including systemic treatment planning and monitoring treatment response.
Kidney cancer, including renal cell carcinoma, may be treated using surgery, immunotherapy or targeted medicines depending on the disease stage and patient characteristics. Dr. Nitin Yashas Murthy has clinical and research experience in renal cell carcinoma immunotherapy, including evaluating treatment response and managing immunotherapy-associated side effects.
Prostate cancer management may involve hormonal treatment, chemotherapy, targeted medicines, radiation or other interventions according to disease stage and individual risk factors. Dr. Nitin Yashas Murthy has expertise in medical treatment of urogenital malignancies, including prostate cancer, and participates in multidisciplinary cancer treatment planning.
Leukaemia is a group of blood cancers affecting blood-forming tissues and circulating blood cells. Treatment varies according to the specific subtype and may involve chemotherapy, targeted medicines or other specialised therapies. Dr. Nitin Yashas Murthy has expertise in haemato-oncology and the medical management of leukaemia.
Lymphoma is a cancer involving lymphocytes, which are immune cells found in the lymphatic system. Different lymphoma subtypes require different diagnostic and treatment approaches. Dr. Nitin Yashas Murthy manages lymphoid malignancies using medical oncology treatments, including systemic therapy and appropriate monitoring of treatment response.
Multiple myeloma is a blood cancer involving plasma cells in the bone marrow. It can affect bones, kidney function and blood cell production. Dr. Nitin Yashas Murthy has experience managing myeloma through systemic anticancer treatment, clinical monitoring and coordination of appropriate supportive care.
Immunotherapy can cause immune-related adverse effects involving organs such as the skin, lungs, liver, bowel and endocrine glands. Dr. Nitin Yashas Murthy has researched immunotherapy toxicities and has experience recognising and managing complications associated with immune checkpoint inhibitors. Early assessment is important when concerning symptoms develop during treatment.
Systemic cancer treatments may cause adverse effects such as nausea, fatigue, reduced blood cell counts, infections and organ-specific complications. Dr. Nitin Yashas Murthy has documented training in administering chemotherapy and targeted treatments while managing related toxicities. Supportive medical care and treatment adjustments depend on the nature and severity of each complication.